MENU

Supply Chain Intelligence about:

Teva Pharmaceutical Works

Company profile   Hungary

See Teva Pharmaceutical Works's products and suppliers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Reveal patterns in global trade

Top countries/regions that supply Teva Pharmaceutical Works
Origin Country/Region
  • Mexico
    128 shipments (97.0%)
  • India
    4 shipments (3.0%)

Easy access to trade data

1 US import shipment
US

U.S. Customs records organized by company

1 U.S. shipment available for Teva Pharmaceutical Works, updated weekly since 2007
Date Supplier Customer Details 43 more fields
2023-02-12 Uquifa Mexico S.A. De C.V.
Teva Pharmaceutical Works Ltd.
XXXXX XXX XXXXXXXXXXX
Bill of lading
Shipment data shows what products a company is trading and more. Learn more

Explore trading relationships hidden in supply chain data

Contact information for Teva Pharmaceutical Works

 
Address
BUDAPEST BU 4042
 
 

Sample Bill of Lading

129 shipment records available

Date
2023-02-12
Shipper Name
Uquifa Mexico Sa De Cv
Shipper Address
CALLE 37 ESTE NO. 126-C.P. CIVAC JIUTEPEC, MORELOS 62578
Consignee Name
Teva Pharmaceutical Works
Consignee Address
BUDAPEST BU 4042
Weight
1241
Weight Unit
KG
Weight in KG
1241.0
Quantity
8
Quantity Unit
PKG
Measure Unit
CM
Shipment Origin
Mexico
Details
1,241.0 kg
From port: Veracruz, Mexico
To port: Port of New Orleans, New Orleans, Louisiana
Place of Receipt
Veracruz
Foreign Port of Lading
Veracruz, Mexico
U.S. Port of Unlading
Port of New Orleans, New Orleans, Louisiana
U.S. Destination Port
Port of New Orleans, New Orleans, Louisiana
Commodity
XXXXX XXX XXXXXXXXXXX
Container
CSNU1258704
Marks Description
XXXXXX
Carrier Name
ORIENT OVERSEAS CONTAINER LINE LTD
Vessel Name
CMA CGM NERVAL
Voyage Number
0VBD6
Bill of Lading Number
OOLU271289386001
Master Bill of Lading Number
OOLU2712893860
Lloyd's Code
9406623
HTS Codes
HTS 9406.90

Recent Panjiva Research about Teva Pharmaceutical Works

20171215-teva-total

Could Croatia Pay The Price For Netanyahu’s Teva Request?

Teva Pharma has launched a significant restructuring program, designed to cut 19% from its cost base after significant price deflation and sector-wide profit warnings from August. That will include “optimization” of its generic drug portfolio, including price rises and product terminations in ... Read more →

20170721-pharma-bubbles

Teva Tumbles as Price Deflation Catches Up With Imports

Generic drug manufacturer Teva cut its full year revenue guidance by 5%, in part because of drug price deflation. Its stock price dropped 23% in response. Falling drug prices have been evident in U.S. import data for some time. Panjiva data shows average prices per kg fell 25% in the three mon... Read more →